Abstract
BNP or NT-proBNP testing has dramatically changed the management of acute heart failure patients by aiding in early recognition, prognostication and treatment. Furthermore, recent studies have shown that natriuretic peptide testing may guide the therapy of the stable chronic heart failure patients in out-patient setting. We will review the understanding of utilizing natriuretic peptide testing to guide heart failure therapy, including present and future directions for this exciting area.
Keywords: Natriuretic peptides, heart failure, coronary artery disease
Current Clinical Pharmacology
Title: Natriuretic Peptide Guided Heart Failure Management
Volume: 4 Issue: 2
Author(s): Asim A. Mohammed and James L. Januzzi Jr.
Affiliation:
Keywords: Natriuretic peptides, heart failure, coronary artery disease
Abstract: BNP or NT-proBNP testing has dramatically changed the management of acute heart failure patients by aiding in early recognition, prognostication and treatment. Furthermore, recent studies have shown that natriuretic peptide testing may guide the therapy of the stable chronic heart failure patients in out-patient setting. We will review the understanding of utilizing natriuretic peptide testing to guide heart failure therapy, including present and future directions for this exciting area.
Export Options
About this article
Cite this article as:
Mohammed A. Asim and Januzzi Jr. L. James, Natriuretic Peptide Guided Heart Failure Management, Current Clinical Pharmacology 2009; 4 (2) . https://dx.doi.org/10.2174/157488409788184945
DOI https://dx.doi.org/10.2174/157488409788184945 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets CPP-Based Bioactive Drug Delivery to Penetrate the Blood-Brain Barrier: A Potential Therapy for Glioblastoma Multiforme
Current Drug Targets Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Current Neuropharmacology Mechanical Support in Cardiogenic Shock Complicating Acute Coronary Syndrome: Ready for Prime Time?
Current Vascular Pharmacology Development of Metal-Based Drugs and Application in Clinical Treatment
The Natural Products Journal No-reflow: Incidence and Detection in The Cath-Lab
Current Pharmaceutical Design Determinants of Perceived Severity of Hypertension and Drug-Compliance in Hypertensive Patients
Cardiovascular & Hematological Disorders-Drug Targets New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design Reactive Oxygen Species, Nitric Oxide and Hypertensive Endothelial Dysfunction
Current Hypertension Reviews Current Status in Iron Chelation in Hemoglobinopathies
Current Molecular Medicine The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Current Status of Computer-Aided Drug Design for Type 2 Diabetes
Current Computer-Aided Drug Design MicroRNAs in Aortic Disease
Current Topics in Medicinal Chemistry Angiotensin II: Role in Skeletal Muscle Atrophy
Current Protein & Peptide Science Incidence and Prevalence of Hypothyroidism in Patients Affected by Chronic Heart Failure: Role of Amiodarone
Endocrine, Metabolic & Immune Disorders - Drug Targets Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Engineering of Therapeutic Proteins Production in Escherichia coli
Current Pharmaceutical Biotechnology Isoindole Derivatives: Propitious Anticancer Structural Motifs
Current Topics in Medicinal Chemistry Na+/Ca2+ Exchange Inhibitors: A New Class of Calcium Regulators
Cardiovascular & Hematological Disorders-Drug Targets Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors
Current Neuropharmacology